According to our new research study on "Hemodialysis and Peritoneal Dialysis Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Product, and End User," the market is expected to grow from US$ 84,610.62 million in 2021 to US$ 130,370.18 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2022 to 2028. The report highlights trends prevailing in the market and factors governing the growth of the hemodialysis and peritoneal dialysis market. Increasing incidence of chronic kidney diseases propel the market growth. However, risks and complications associated with dialysis limit the market growth.
The National Kidney Foundation report states that, there are two kinds of dialysis. In hemodialysis, blood is pumped out of patient's body to an artificial kidney machine, and return to the patient's body by tubes that connect to the machines. In peritoneal dialysis, the inside lining of patient's own belly acts as a natural filter. Major factors driving the market growth include the increasing prevalence of kidney diseases, and increasing prevalence of diabetes. Additionally, the market strategies by key players is likely to emerge as a significant future trend in the market during the forecast period. However, risks and complications with dialysis hamper the hemodialysis and peritoneal dialysis market growth.
According to the National Kidney Foundation report, 10% of the population globally is affected by chronic kidney disease (CKD), and millions die annually owing to having access to affordable treatment. Additionally, over 2 million people worldwide currently receive treatment with dialysis to stay alive. Hemodialysis (HD) is the most common renal replacement therapy (RRT) modality practiced worldwide. For example, the number of HD stations in India was estimated to be 12,881 in 2018. The Union Government announced a National Dialysis Program in 2016 focusing on setting up eight-station dialysis facilities in 688 districts in India, offering HD to poor patients. Further, the Centers for Disease Control and Prevention (CDC) report states that ~ 36 million adults are suffering from chronic kidney diseases (CKD) in the US. Every 24 hours, 360 people begin dialysis treatment for kidney failure. Moreover, in the past few years, the requirement for dialysis has increased stupendously. Therefore, the increasing prevalence of End-Stage Renal Disease (ESRD) drives the adoption of hemodialysis and peritoneal dialysis.
Increasing adoption of self-care dialysis and rising initiatives by competitive players for introducing advanced products and services propel the growth of the hemodialysis and peritoneal dialysis market. According to the report by the American Association of Kidney Patients (AAKP), self-care (home) dialysis therapies, such as peritoneal dialysis and home hemodialysis, are receiving significant attention for patients suffering from CKD across the world. Also, the adoption of hemodialysis and peritoneal dialysis as effective therapies and treatments for patients suffering from ESRD is increasing. Therefore, if self-care benefits are identified, it may prove as one of the remarkable therapy options for patients suffering from CKD that may include improved healthcare outcomes.
Rising number of strategies by leading players in the hemodialysis and peritoneal dialysis market drives the overall market growth. For instance, in December 2020, Medtronic announced the launch of the first and only pediatric and neonatal acute dialysis machine in the US. The newly launched product, namely "Carpediem" system, is designed for treating patients requiring renal replacement therapy weighing between 2.5 and 10 kilograms (5.5 to 22 pounds). The newly launched product has been successfully installed and is used in Cincinnati Children's Hospital Medical Center.